PSI Medical Statistics Careers Event
This event is aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.
The training course for statisticians and statistical programmers new to the industry, widely known as the "Introduction to Industry Training Course", has been running since 1986. It aims to broaden the participants' knowledge and appreciation of the drug development process from discovery through to marketing. It enables participants to learn about the role and interaction of Statistics with other disciplines within the industry and also allows them to meet and exchange ideas with statisticians and programmers of a similar level of experience.
There are six sessions (Research, Toxicology, DM/CROs, Clinical Trials, Licensing and Re-imbursement, Marketing) hosted by six companies, each lasting one or two days. Each session includes talks by relevant specialists, workshops to encourage active involvement from the participants and guided tours of relevant work areas.
For more information about the course please click here
This event is aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Over the course of two sessions, a panel of 8 esteemed speakers will give an introduction to the topic, followed by a presentation of case studies & interactive panel discussion.
Over the past years, areas of clinical development and patient access / health technology assessment (HTA) have moved closer together. However, both areas differ in how they approach their respective research or policy questions. While the estimand framework is being the focus in clinical development, HTA is being viewed through the lens of the PICO framework. This webinar brings together Antonio Remiro-Azocar, Robert Hemmings and Nicholas Latimer, who are renowned experts in the respective fields. They will provide an introduction to these three concepts, illustrated with examples.
In a world buzzing with artificial intelligence, can you distinguish between what's AI-generated and what's not? The session promises to showcase machine-generated content, challenging your perceptions, and luring you into the fascinating world of AI technology.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This course consists of 5 x 2 hour training sessions run over 5 weeks. For those who cannot attend the date and time provided, there will be a recording provided and a follow-up 1 hour Q and A session. Participation will provide access to extensive course materials in the form of a “bookdown” site. However, this is designed as a hands-on, interactive course. Both you and the trainers will work entirely within the RStudio Cloud development environment, which will remain accessible between virtual sessions in order to further explore and cement your understanding.
The Pre-Clinical SIG Workshop returns for 2024, bringing you a two half-days event, starting with a course on pre-clinical design of experiments. We will also have speakers on topics such as statistics and genetic toxicology, the new and promising OMARS DOE and ANOVA-type.
Are you a member of PSI looking to further your career or help develop others - why not sign up to the PSI Mentoring scheme? You can expand your network, improve your leadership skills and learn from more senior colleagues in the industry.
Suitable for PhD candidates in statistics or a related discipline. Full-time for 10-12 weeks in Summer 2024. Remote working, from the United States or the United Kingdom
The Principal DMC Statistician works primarily in the production and quality control.
Head of Respiratory Vaccines Clinical Statistics role has portfolio leadership for statisticians aligned to vaccine development in the area of Respiratory disease, providing statistical leadership for Clinical Development and Commercialization.
BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.